Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 4/2013

01-04-2013 | Interventional Cardiology (S Rao, Section Editor)

Combining PCI and CABG: the Role of Hybrid Revascularization

Authors: Kelly D. Green, Donald R. Lynch Jr., Tyffany P. Chen, David Zhao

Published in: Current Cardiology Reports | Issue 4/2013

Login to get access

Abstract

Hybrid coronary revascularization combines the benefits of both percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in the treatment of multivessel coronary artery disease (CAD) by combining the benefits of the LIMA-to-LAD graft and drug eluting stent (DES) to non-LAD regions. Through this approach, a patient receives the long-term benefit of the LIMA graft and avoids the morbidity of a full sternotomy and saphenous vein grafts. Available data related to outcomes following hybrid revascularization is limited to small studies. In this review we seek to provide an overview of hybrid revascularization in the era of modern drug eluting stent technology, discuss appropriate patient selection, and comment on future trial design. Additionally, we review the recent literature pertaining to the hybrid approach.
Literature
1.
Angelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet. 1996;347(9003):757–8.PubMedCrossRef
2.
Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314(1):1–6.PubMedCrossRef
3.
Yeung AC, Leon MB, Jain A, et al. Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries. J Am Coll Cardiol. 2011;57(17):1778–83.PubMedCrossRef
4.
Puskas JD, Williams WH, Mahoney EM, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA. 2004;291(15):1841–9.PubMedCrossRef
5.
Weisz G, Leon MB, Holmes DR, et al. Five-year follow-up after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2009;53(17):1488–97.PubMedCrossRef
6.
Alfonso F, Perez-Vizcayno M-J, Hernandez R, et al. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv. 2008;72(4):459–67.PubMedCrossRef
7.
Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation. 1995;91(9):2335–44.PubMedCrossRef
8.
Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111(25):3435–42.PubMedCrossRef
9.
•• Leacche M, Byrne J, Solenkova N, Reagan B, et al. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE. J Thorac Cardiovasc Surg. 2012;1–10. This study identifies patient populations best suited for hybrid therapy using SYNTAX and euroSCORE.
10.
Bachinsky WB, Abdelsalam M, Boga G, Kiljanek L, Mumtaz M, McCarty C. Comparative study of same sitting hybrid coronary artery revascularization versus off-pump coronary artery bypass in multivessel coronary artery disease. J Interv Cardiol. 2012;25(5):460–8. doi:10.​1111/​j.​1540-8183.​2012.​00752.​x.PubMedCrossRef
11.
Rab ST, Douglas Jr JS, Lyons E, et al. Hybrid coronary revascularization for the treatment of left main coronary stenosis: a feasibility study. Cathet Cardiovasc Interv. 2011;80(2):238–44.CrossRef
12.
Fedakar A, Tasar M, Rabus MB, Alsalehi S, Toker ME, Balkanay M. Hybrid coronary revascularization for the treatment of left main coronary artery disease in high-risk patients. Heart Surg Forum. 2012;15(1):E51–5.PubMedCrossRef
13.
• Halkos ME, Vassiliades TA, Douglas JS, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2011;92(5):1695–702. This is the largest published series to date, concluding that Hybrid therapy is safe and effective in appropriately selected patients.PubMedCrossRef
14.
Hu S-S, Xiong H, Zheng Z, et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery disease. Heart Surg Forum. 2012;15(1):E18–22.PubMedCrossRef
15.
The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600–1606.
16.
Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.PubMedCrossRef
17.
Willerson JT. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. Circulation. 1996;94(6):1194.PubMedCrossRef
18.
The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) investigators. N Engl J Med. 1996;335(4):217–225.
19.
Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–54.PubMedCrossRef
20.
Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41(8):1293–304.PubMedCrossRef
21.
Mercado N, Wijns W, Serruys PW, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005;130(2):512–9.PubMedCrossRef
22.
Yan TD, Padang R, Poh C, et al. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg. 2011;141(5):1134–44.PubMedCrossRef
23.
Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization. J Am Coll Cardiol. 2009;53(3):232–41.PubMedCrossRef
24.
Us MH, Basaran M, Yilmaz M, et al. Hybrid coronary revascularization in high-risk patients. Tex Heart Inst J. 2006;33(4):458–62.PubMed
25.
Umakanthan R, Leacche M, Zhao DX, Gallion AH, Mishra PC, Byrne JG. Hybrid options for treating cardiac disease. Semin Thorac Cardiovasc Surg. 2011;23(4):274–80.PubMedCrossRef
26.
Lee M-S, Faxon DP. Revascularization of left main coronary artery disease. Cardiol Rev. 2011;19(4):177–83.PubMedCrossRef
27.
Balaguer JM, Umakanthan R, Leacche M, Byrne JG. Minimally invasive cardiac surgery. Curr Probl Surg. 2012;49(9):529–49.PubMedCrossRef
28.
Narasimhan S, Srinivas VS, DeRose Jr JJ. Hybrid coronary revascularization. Cardiol Rev. 2011;19(3):101–7.PubMedCrossRef
29.
de Canniere D, Jansens JL, Goldschmidt-Clermont P, Barvais L, Decroly P, Stoupel E. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with “on-pump” double bypass grafting. Am Heart J. 2001;142(4):563–70.PubMedCrossRef
30.
Bonatti J, Lehr EJ, Vesely M, et al. Hybrid coronary revascularization – techniques and outcome. Eur Surg. 2011;43(4):198–204.CrossRef
31.
Lloyd CT, Calafiore AM, Wilde P, et al. Integrated left anterior small thoracotomy and angioplasty for coronary artery revascularization. Ann Thorac Surg. 1999;68(3):908–11. discussion 911–2.PubMedCrossRef
32.
Lewis BS, Porat E, Halon DA, et al. Same-day combined coronary angioplasty and minimally invasive coronary surgery. Am J Cardiol. 1999;84(10):1246–7. A8.PubMedCrossRef
33.
Zenati M, Cohen HA, Griffith BP. Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Sur. 1999;117(3):439–44. discussion 444–6.CrossRef
34.
Wittwer T, Cremer J, Klima U, Wahlers T, Haverich A. Myocardial “hybrid” revascularization: intermediate results of an alternative approach to multivessel coronary artery disease. J Thorac Cardiovasc Sur. 1999;118(4):766–7.CrossRef
35.
Isomura T, Suma H, Horii T, Sato T, Kobashi T, Kanemitsu H. Minimally invasive coronary artery revascularization: off-pump bypass grafting and the hybrid procedure. Ann Thorac Surg. 2000;70(6):2017–22.PubMedCrossRef
36.
Presbitero P, Nicolini F, Maiello L, et al. “Hybrid” percutaneous and surgical coronary revascularization: selection criteria from a single-center experience. Ital Heart J. 2001;2(5):363–8.PubMed
37.
Cisowski M, Morawski W, Drzewiecki J, et al. Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg. 2002;22(2):261–5.PubMedCrossRef
38.
Stahl KD, Boyd WD, Vassiliades TA, Karamanoukian HL. Hybrid robotic coronary artery surgery and angioplasty in multivessel coronary artery disease. Ann Thorac Surg. 2002;74(4):S1358–62.PubMedCrossRef
39.
Riess F-C, Bader R, Kremer P, et al. Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up. Ann Thorac Surg. 2002;73(6):1849–55.PubMedCrossRef
40.
Lee MS, Wilentz JR, Makkar RR, et al. Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. J Invasive Cardiol. 2004;16(8):419–25.PubMed
41.
Davidavicius G, Van Praet F, Mansour S, et al. Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve-guided percutaneous coronary intervention. Circulation. 2005;112(9 Suppl):I317–22.PubMed
42.
Kiaii B, McClure RS, Kostuk WJ, et al. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest. 2005;128(6):4046–8.PubMedCrossRef
43.
Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32(17):2125–34.PubMedCrossRef
44.
Katz MR, Van Praet F, de Canniere D, et al. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation. 2006;114(1 Suppl):I473–6.PubMed
45.
Vassiliades TAJ, Douglas JS, Morris DC, et al. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. J Thorac Cardiovasc Surg. 2006;131(5):956–62.PubMedCrossRef
46.
Gilard M, Bezon E, Cornily JC, et al. Same-day combined percutaneous coronary intervention and coronary artery surgery. Cardiology. 2007;108(4):363–7.PubMedCrossRef
47.
Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg. 2008;135(2):367–75.PubMedCrossRef
48.
Bonatti J, Schachner T, Bonaros N, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology. 2008;110(2):92–5.PubMedCrossRef
49.
Reicher B, Poston RS, Mehra MR, et al. Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008;155(4):661–7.PubMedCrossRef
50.
Holzhey DM, Jacobs S, Mochalski M, et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg. 2008;86(6):1856–60.PubMedCrossRef
51.
Hu S, Li Q, Gao P, et al. Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease. Ann Thorac Surg. 2011;91(2):432–8.PubMedCrossRef
Metadata
Title
Combining PCI and CABG: the Role of Hybrid Revascularization
Authors
Kelly D. Green
Donald R. Lynch Jr.
Tyffany P. Chen
David Zhao
Publication date
01-04-2013
Publisher
Current Science Inc.
Published in
Current Cardiology Reports / Issue 4/2013
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-013-0351-9

Other articles of this Issue 4/2013

Current Cardiology Reports 4/2013 Go to the issue

Peripheral Vascular Disease (M Shishehbor, Section Editor)

The ABC’s of Wound Care

Ischemic Heart Disease (D Mukherjee, Section Editor)

HDL Cholesterol and Cardiovascular Outcomes: What Is the Evidence?

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Functional Impairment in Peripheral Artery Disease and How to Improve It in 2013

Interventional Cardiology (S Rao, Section Editor)

Identification and Management of Complications of Transradial Procedures

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Management of Acute Ischemic Stroke

Valvular Heart Disease (V Nkomo, Section Editor)

Transcatheter Aortic Valve Replacement: Current Application and Future Directions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits